BAX Stock Summary and Trading Ideas (Baxter International | NYSE:BAX)

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Baxter International trades on the NYSE stock market under the symbol BAX.

As of March 10, 2026, BAX stock price declined to $17.53 with 3,889,161 million shares trading.

BAX has a beta of 1.44, meaning it tends to be more sensitive to market movements. BAX has a correlation of 0.22 to the broad based SPY ETF.

BAX has a market cap of $9.02 billion. This is considered a Mid Cap stock.

Last quarter Baxter International reported $3 billion in Revenue and $.44 earnings per share. This beat revenue expectation by $163 million and missed earnings estimates by -$.09.

In the last 3 years, BAX traded as high as $50.21 and as low as $17.00.

The top ETF exchange traded funds that BAX belongs to (by Net Assets): VTI, VOO, VB, RSP, VBR.

BAX has underperformed the market in the last year with a price return of -51.1% while the SPY ETF gained +19.1%. BAX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.4% and -17.5%, respectively, while the SPY returned -0.3% and -0.5%, respectively.

BAX support price is $17.37 and resistance is $18.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BAX shares will trade within this expected range on the day.